|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
MA50819A
(fr)
|
2014-12-23 |
2021-04-07 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers
|
|
US9422547B1
(en)
|
2015-06-09 |
2016-08-23 |
Gigagen, Inc. |
Recombinant fusion proteins and libraries from immune cell repertoires
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
AU2018273914A1
(en)
|
2017-05-24 |
2019-11-14 |
Pandion Operations, Inc. |
Targeted immunotolerance
|
|
US10946068B2
(en)
|
2017-12-06 |
2021-03-16 |
Pandion Operations, Inc. |
IL-2 muteins and uses thereof
|
|
US10174091B1
(en)
|
2017-12-06 |
2019-01-08 |
Pandion Therapeutics, Inc. |
IL-2 muteins
|
|
AU2018395397A1
(en)
*
|
2017-12-28 |
2020-08-06 |
Gritstone Bio, Inc. |
Antigen-binding proteins targeting shared antigens
|
|
KR102892744B1
(ko)
*
|
2018-04-19 |
2025-11-28 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
Mage-b2 특이성을 갖는 t 세포 수용체 및 이의 용도
|
|
CN112739375B
(zh)
*
|
2018-08-17 |
2025-10-28 |
磨石生物公司 |
靶向共同抗原的抗原结合蛋白
|
|
CN111138522B
(zh)
*
|
2018-11-06 |
2023-01-24 |
香雪生命科学技术（广东）有限公司 |
衍生自afp的肿瘤抗原短肽
|
|
CN111138521B
(zh)
*
|
2018-11-06 |
2022-10-28 |
香雪生命科学技术（广东）有限公司 |
源自于afp抗原的短肽
|
|
GB2613715B
(en)
*
|
2019-02-20 |
2023-12-06 |
Fred Hutchinson Cancer Center |
Binding proteins specific for RAS neoantigens and uses thereof
|
|
WO2020191365A1
(en)
|
2019-03-21 |
2020-09-24 |
Gigamune, Inc. |
Engineered cells expressing anti-viral t cell receptors and methods of use thereof
|
|
EP3714941A1
(en)
*
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
US20200318068A1
(en)
*
|
2019-04-04 |
2020-10-08 |
Immatics US, Inc. |
Use of retinoic acid in t-cell manufacturing
|
|
MX2021012207A
(es)
|
2019-04-05 |
2021-12-10 |
Rootpath Genomics Inc |
Composiciones y métodos para ensamblaje de genes del receptor de linfocitos t.
|
|
US20220213167A1
(en)
*
|
2019-05-03 |
2022-07-07 |
Gigamune, Inc. |
Engineered cells expressing anti-tumor t cell receptors and methods of use thereof
|
|
MA55911A
(fr)
|
2019-05-08 |
2022-03-16 |
2Seventy Bio Inc |
Lymphocytes t génétiquement modifiés
|
|
AU2020279240A1
(en)
|
2019-05-20 |
2021-12-23 |
Pandion Operations, Inc. |
MAdCAM targeted immunotolerance
|
|
EP3760217A1
(en)
*
|
2019-07-01 |
2021-01-06 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Cd5 specific t cell receptor cell or gene therapy
|
|
US20220251235A1
(en)
*
|
2019-07-09 |
2022-08-11 |
Medigene Immunotherapies Gmbh |
Magea10 specific t cell receptors and their use
|
|
AU2020315598B2
(en)
|
2019-07-16 |
2024-12-12 |
Gilead Sciences, Inc. |
HIV vaccines and methods of making and using
|
|
CN112300261B
(zh)
*
|
2019-07-23 |
2023-03-17 |
香雪生命科学技术（广东）有限公司 |
一种衍生自afp的肿瘤抗原短肽
|
|
CN114728179A
(zh)
*
|
2019-08-19 |
2022-07-08 |
潘迪恩运营公司 |
利用pd-1激动剂的靶向免疫耐受
|
|
EP3786178A1
(en)
|
2019-08-30 |
2021-03-03 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Tcr constructs specific for ebv-derived antigens
|
|
WO2021048381A1
(en)
*
|
2019-09-13 |
2021-03-18 |
Evaxion Biotech Aps |
Method for identifying stable mhc binding peptides using mass spectrometry
|
|
US20220372092A1
(en)
*
|
2019-10-18 |
2022-11-24 |
Board Of Regents, The University Of Texas System |
Hla-restricted vcx/y peptides and t cell receptors and use thereof
|
|
WO2021092094A1
(en)
*
|
2019-11-04 |
2021-05-14 |
Gritstone Oncology, Inc. |
Antigen-binding proteins targeting shared neoantigens
|
|
CA3157411A1
(en)
*
|
2019-11-15 |
2021-05-20 |
Karin Jooss |
Antigen-binding proteins targeting shared neoantigens
|
|
CU20220029A7
(es)
|
2019-11-18 |
2023-01-16 |
BioNTech SE |
Receptores de tcr de prame
|
|
CN112898399A
(zh)
*
|
2019-12-03 |
2021-06-04 |
香雪生命科学技术（广东）有限公司 |
源自于afp抗原的短肽
|
|
CN115960206A
(zh)
*
|
2019-12-13 |
2023-04-14 |
南京大户生物科技有限公司 |
原发性肝癌相关抗原的胸腺依赖性淋巴细胞抗原表位肽及其应用
|
|
CN113072636B
(zh)
*
|
2020-01-06 |
2024-05-28 |
香雪生命科学技术（广东）有限公司 |
一种识别afp的t细胞受体及其编码序列
|
|
US11981715B2
(en)
|
2020-02-21 |
2024-05-14 |
Pandion Operations, Inc. |
Tissue targeted immunotolerance with a CD39 effector
|
|
CN113321725B
(zh)
*
|
2020-02-28 |
2024-06-11 |
香雪生命科学技术（广东）有限公司 |
一种识别afp的t细胞受体
|
|
CN113321727B
(zh)
*
|
2020-02-28 |
2024-04-09 |
香雪生命科学技术（广东）有限公司 |
一种识别afp抗原短肽的t细胞受体及其编码序列
|
|
US11896619B2
(en)
*
|
2020-03-10 |
2024-02-13 |
Massachusetts Institute Of Technology |
Compositions and methods for immunotherapy of NPM1c-positive cancer
|
|
IL296242A
(en)
*
|
2020-03-10 |
2022-11-01 |
Massachusetts Inst Technology |
Methods for generating engineered memory-like nk cells and compositions thereof
|
|
CN113493505B
(zh)
*
|
2020-03-20 |
2026-07-10 |
香雪生命科学技术（广东）有限公司 |
识别afp抗原的高亲和力tcr
|
|
CN113621070A
(zh)
|
2020-05-06 |
2021-11-09 |
华夏英泰（北京）生物技术有限公司 |
一种t细胞抗原受体、其多聚体复合物及其制备方法和应用
|
|
EP4153618A4
(en)
*
|
2020-05-18 |
2024-06-26 |
Board of Regents, The University of Texas System |
MANIPULATED T-CELL RECEPTORS AND METHODS OF USE
|
|
WO2021236638A1
(en)
*
|
2020-05-19 |
2021-11-25 |
Amgen Inc. |
Mageb2 binding constructs
|
|
WO2021252517A1
(en)
*
|
2020-06-09 |
2021-12-16 |
Board Of Regents, The University Of Texas System |
Engineered t cell receptors and methods of use
|
|
JP7391208B2
(ja)
|
2020-07-08 |
2023-12-04 |
エルジー エナジー ソリューション リミテッド |
バッテリーパック及びそれを含む自動車
|
|
US20240059797A1
(en)
*
|
2020-07-29 |
2024-02-22 |
Gritstone Bio, Inc. |
Engineered multi-specific antibodies and related methods of use and manufacture
|
|
AU2021336399A1
(en)
*
|
2020-09-04 |
2023-05-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T cell receptors recognizing r273c or y220c mutations in p53
|
|
CA3193172A1
(en)
*
|
2020-09-24 |
2022-03-31 |
Kathrin DAVARI |
Mage-a3 specific t cell receptors and their use
|
|
IL301543A
(en)
*
|
2020-09-24 |
2023-05-01 |
Medigene Immunotherapies Gmbh |
Prame specific t cell receptors and uses thereof
|
|
WO2022082030A2
(en)
|
2020-10-15 |
2022-04-21 |
Gritstone Bio, Inc. |
Antigen-binding proteins and related methods of use
|
|
CN116710473A
(zh)
*
|
2020-10-23 |
2023-09-05 |
根路径基因组学公司 |
用于t细胞受体鉴定的组合物和方法
|
|
KR20230088833A
(ko)
*
|
2020-10-23 |
2023-06-20 |
루트패스 제노믹스, 인크. |
T-세포 수용체 식별을 위한 조성물 및 방법
|
|
CA3200661A1
(en)
*
|
2020-11-05 |
2022-05-12 |
Board Of Regents, The University Of Texas System |
Engineered t cell receptors targeting egfr antigens and methods of use
|
|
CA3202466A1
(en)
|
2021-01-14 |
2022-07-21 |
Jiani LI |
Hiv vaccines and methods of using
|
|
WO2022155503A1
(en)
*
|
2021-01-14 |
2022-07-21 |
Gritstone Bio, Inc. |
Multi-specific antibodies and methods of use
|
|
EP4294831A1
(en)
*
|
2021-02-16 |
2023-12-27 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Hla class i-restricted t cell receptors against cd22
|
|
EP4304726A1
(en)
|
2021-03-09 |
2024-01-17 |
CDR-Life AG |
Mage-a4 peptide-mhc antigen binding proteins
|
|
US12435444B2
(en)
|
2021-03-09 |
2025-10-07 |
Cdr-Life Ag |
Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same
|
|
KR20240005714A
(ko)
*
|
2021-03-29 |
2024-01-12 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
Sars-cov-2 항원을 표적화하는 펩티드 및 조작된 t 세포 수용체 및 사용 방법
|
|
JP2024512808A
(ja)
*
|
2021-04-05 |
2024-03-19 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｃａｌｒ及びｊａｋ２ｔ細胞受容体
|
|
WO2022229966A1
(en)
|
2021-04-29 |
2022-11-03 |
Yeda Research And Development Co. Ltd. |
T cell receptors directed against ras-derived recurrent neoantigens and methods of identifying same
|
|
EP4091627A1
(en)
*
|
2021-05-21 |
2022-11-23 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Tcr constructs specific for magea4-derived epitopes
|
|
KR20240013750A
(ko)
*
|
2021-05-25 |
2024-01-30 |
메모리얼 슬로안 케터링 캔서 센터 |
Ras 돌연변이를 표적으로 하는 t 세포 수용체 및 그의 용도
|
|
US20250073323A1
(en)
*
|
2021-08-06 |
2025-03-06 |
Anyadi, Llc |
Process for producing personalized cancer immunotherapy
|
|
WO2023050063A1
(zh)
*
|
2021-09-28 |
2023-04-06 |
溧阳瑅赛生物医药有限公司 |
一种识别hla-a*02:01/e629-38的tcr及其应用
|
|
CA3236237A1
(en)
*
|
2021-10-25 |
2023-05-04 |
Board Of Regents, The University Of Texas System |
Peptides and engineered t cell receptors targeting mage-a4 antigen and methods of use
|
|
EP4423143A4
(en)
*
|
2021-10-29 |
2025-10-01 |
Yafei Hou |
T CELL RECEPTOR RECOGNIZING R175H MUTATION IN P53 AND ITS APPLICATION
|
|
EP4472742A1
(en)
*
|
2022-02-03 |
2024-12-11 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023164455A2
(en)
*
|
2022-02-23 |
2023-08-31 |
Aloe Therapeutics Inc |
Compositions and methods to modulate the immune system
|
|
NL2031118B1
(en)
*
|
2022-03-01 |
2023-09-07 |
Academisch Ziekenhuis Leiden |
T cell receptors directed against transcription factor wt1 and uses thereof
|
|
CN116836261A
(zh)
*
|
2022-03-24 |
2023-10-03 |
香雪生命科学技术（广东）有限公司 |
一种识别mage-a4抗原的高亲和力tcr及其序列和应用
|
|
CN117264043B
(zh)
*
|
2022-06-14 |
2024-05-10 |
上海镔铁生物科技有限责任公司 |
靶向kras g12v突变多肽的t细胞受体及其用途
|
|
EP4587046A1
(en)
|
2022-09-14 |
2025-07-23 |
CDR-Life AG |
Mage-a4 peptide dual t cell engagers
|
|
CN120302989A
(zh)
*
|
2022-10-05 |
2025-07-11 |
帝斯肯医疗公司 |
Magea1免疫原性肽、识别magea1免疫原性肽的结合蛋白和其用途
|
|
CN116158405B
(zh)
*
|
2023-01-30 |
2024-04-26 |
西北农林科技大学 |
一种提高奶山羊后代母羔率的方法
|
|
WO2025064738A1
(en)
*
|
2023-09-22 |
2025-03-27 |
Regeneron Pharmaceuticals, Inc. |
Dntt 250-258 off-target peptides and uses thereof
|
|
AU2024374117A1
(en)
*
|
2023-10-30 |
2026-04-09 |
T-Knife Gmbh |
Antigen-recognizing construct capable of binding to a frame peptide and a t cell receptor
|
|
CN118256604B
(zh)
*
|
2024-04-16 |
2024-11-19 |
华中科技大学 |
一种利用人工抗原呈递细胞进行免疫原性肿瘤新抗原筛选与鉴定方法
|